Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Explore essential factors to consider when choosing cash back credit cards. Make informed decisions to maximize your rewards.
23,660 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A new heavyweight in crypto treasuries is nearing a public listing. Evernorth, with a sizable XRP stash, aims to rede...
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Tech stocks are leading the charge, lifting major indices to new highs. This guide breaks down the drivers, the bigge...
A Florida man with a provocative nickname has pleaded guilty in a sprawling crypto fraud tied to a project that promi...
DeepMind’s 2010 seed and Google’s 2014 buyout sparked debate about exit timing in AI. This report weighs whether the ...
Apple may be eyeing a breakthrough to reduce on-device memory needs, a move that could shake Micron and the broader m...
The quantum race isn’t just about flashy qubit players. The real upside sits in the infrastructure that makes quantum...
Robotaxi chatter tends to focus on all-or-nothing automation. This article explains why Uber's hybrid network could b...
A major fund trimmed its ACI Worldwide position, nudging the stock to trail the S&P 500 by a noticeable gap. This sto...
Investing in memory chips means weighing volatility against opportunity. This article digs into could micron technolo...
SpaceX’s market cap vaults above $3 trillion, turning a $60 billion Cursor acquisition into a relative rounding error...